Marrone Bio Innovations announces distribution partnership in Western Canada

DAVIS, Calif., April 16, 2019 (GLOBE NEWSWIRE) -- (NASDAQ:MBII) (MBI), a leading developer of biological crop protection and plant health solutions, today announced that it has appointed TerraLink Horticulture, Inc. (“TerraLink”) as a distributor of the Regalia® Maxx Biofungicide in Western Canada.

TerraLink has been a leading supplier of crop input products to Western Canada since 1973. Based out of Abbotsford, BC, TerraLink primary focuses on providing farmers, production managers and professional growers with a comprehensive suite of fertilizers, seeds, growing media, hard goods and crop protection products.

“We are pleased to announce our distribution partnership with TerraLink, which we expect to stimulate sales of our incredible Regalia Maxx Biofungicide throughout Western Canada,” said André Trépanier, director of marketing at Marrone Bio Innovations. “Now that we have received approval for our newly expanded label by the Canadian authorities, we are seeing a notable increase in grower inquiries due to its safety, crop quality and yield benefits as compared to existing chemical products. The expanded label also offers a unique value proposition to producers of medicinal plants in Canada, as it does not carry the same toxicity risk that traditional chemical pesticides do. We are looking forward to working with TerraLink to bring a new generation of sustainable farming practices to Western Canada,” concluded Trépanier.

About Regalia Maxx Biofungicide

Regalia Maxx Biofungicide contains a plant extract made from the giant knotweed (Reynoutria sachalinensis) plant. The powerful biofungicide induces the plants' natural defense mechanisms against tough fungal and bacterial diseases such as powdery mildew and gray mold (Botrytis). Regalia Maxx Biofungicide is registered on a wide range of crops including greenhouse grown ornamentals, cucurbits, tomatoes, grapes, hops, apples, trees fruits, blueberries and strawberries, turf and more. Regalia Maxx Biofungicide is exempt from residue tolerances, and OMRI listed, making it a good choice for organic and conventionally grown crops. Regalia Maxx Biofungicide can be used in rotation or as a tank mix partner with most commercially available products.

About Marrone Bio Innovations

(NASDAQ: MBII) leads the movement to more a sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment that support a better tomorrow for farmers, turf managers and consumers around the globe. MBI has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies to rapidly develop seven effective and environmentally responsible pest management active ingredients and nine commercial products to help customers operate more sustainably while uniquely improving plant health and increasing crop yields. Supported by a robust portfolio of over 400 issued and pending patents around its superior natural product chemistry, MBI’s currently available commercial products, in addition to the Regalia®  family, are Stargus®, Grandevo®, Venerate®, Majestene®, Haven® and Amplitude®, Zelto® and Zequanox®.

Learn more about Marrone Bio Innovations at . Follow us on social media: , and .

Marrone Bio Innovations Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, including examples regarding the potential of and market for MBI’s Regalia Maxx product and its use and value to growers should not be relied upon as representing MBI’s views as of any subsequent date. Examples of such statements include the potential of the MBI’s products and market projections. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company’s control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including weather, regulatory and other factors affecting demand for the MBI’s products, any difficulty in marketing MBI’s products in its target markets, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers. Additional information that could lead to material changes in MBI’s performance is contained in its filings with the SEC. MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of current information, future events or otherwise.

MBI Investor Relations:

Greg Falesnik,  Managing Director

MZ Group – MZ North America

949-385-6449

MBI Trade Public Relations:

Alicia Gillman, Marketing Communications

480-889-4219

Email:

                       

Marrone Bio Innovations Product Development Contact:

André Trépanier, Director of Marketing

Main: 530-750-2800

Email: